Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von James Milburn und 20 weiteren Autor:innen. Beteiligte Einrichtung: Botswana Harvard Health Partnership, Gaborone, Botswana. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, UK Department of Health and Social Care, NIH HHS.
Abstract (Originalsprache)
Background
Cryptococcal meningitis (CM) causes substantial mortality in African countries with a high prevalence of human immunodeficiency virus (HIV), despite advances in disease management and increasing antiretroviral therapy (ART) coverage. Reliable diagnosis of CM is cheap and more accessible than other indicators of advanced HIV disease burden such as CD4 testing or investigation for disseminated tuberculosis; therefore, monitoring CM incidence has the potential to serve as a valuable metric of HIV programmatic success.
Methods
Botswana national meningitis surveillance data from 2015 to 2022 were obtained from electronic health records. All electronic laboratory records from cerebrospinal fluid samples analyzed within government healthcare facilities in Botswana were extracted from a central online repository. Adjustments for missing data were made through triangulation with prospective cohort study datasets. CM case frequency was enumerated using a case definition and incidence calculated using national census data.
Results
A total of 1744 episodes of CM were identified; incidence declined from 15.0 (95% confidence interval [CI], 13.4–16.7) cases/100 000 person-years in 2015 to 7.4 (95% CI, 6.4–8.6) cases/100 000 person-years in 2022. However, the rate of decline slowed following the introduction of universal treatment in 2016. The highest incidence was observed in men and individuals aged 40–44 years. The proportion of cases diagnosed through cryptococcal antigen testing increased from 35.5% to 86.3%.
Conclusions
CM incidence has decreased in Botswana following expansion of ART coverage but persists at a stubbornly high incidence. Most cases are now diagnosed through the cheap and easy-to-use cryptococcal antigen test, highlighting the potential of using CM as key metric of program success in the Treat All era.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Botswana Harvard Health Partnership, Gaborone, Botswana.
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.
- Botswana-University of Maryland School of Medicine Health Initiative.
- Botswana Ministry of Health and Wellness, Gaborone.
- Department of Infectious Disease Epidemiology and International Health, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
- Botswana-UPenn Partnership, Gaborone.
ORCID-Profile: James Milburn, Daniel Grint
Förderung
- National Institute for Health and Care Research
- UK Department of Health and Social Care
- NIH HHS
- National Institutes of Health
Zitieren
APA
Milburn, J., Ntwayagae, O., Suresh, R., Ngoni, K., Northcott, C., Penney, J., Kinsella, M., Mechie, I., Ensor, S., Thamae, G., Leeme, T., Lawrence, D. S., Chebani, T., Grint, D., Tenforde, M. W., Avalos, A., Ramaabya, D., Ogando, J., Mokomane, M., …, & Jarvis, J. N. (2024). Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae066
Vancouver
Milburn J, Ntwayagae O, Suresh R, Ngoni K, Northcott C, Penney J, et al. Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae066
BibTeX
@article{Milburn2024,
author = {Milburn, James and Ntwayagae, Ookeditse and Suresh, Rachita and Ngoni, Kebatshabile and Northcott, Cassie and Penney, James and Kinsella, Matthew and Mechie, Imogen and Ensor, Samuel and Thamae, Goitseone and Leeme, Tshepo and Lawrence, David S and Chebani, Tony and Grint, Daniel and Tenforde, Mark W and Avalos, Ava and Ramaabya, Dinah and Ogando, Justus and Mokomane, Margaret and Mine, Madisa and Jarvis, Joseph N},
title = {Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae066}
}
EUVIMED